I agree that this site is using cookies. You can find further informations here.
X
Stroissnig, Heimo
17  results:
Search for persons X
?
1

Randomized, double-blind, multicenter study to evaluate eff..:

Feldman, Steven R ; Reznichenko, Nataliya ; Berti, Fausto...
Expert Opinion on Biological Therapy.  23 (2023)  8 - p. 759-771 , 2023
Link: https://doi.org/10.1080/..
 
?
2

42601 Assessment of Bioequivalence Between Candidate Biosim..:

Berti, Fausto ; Wynne, Chris ; Stroissnig, Heimo...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB123 , 2023
Link: https://doi.org/10.1016/..
 
?
3

A randomized, double-blind, 3-arm, parallel study assessing..:

Wynne, Christopher ; Hamilton, Paul ; McLendon, Kristi...
Expert Opinion on Investigational Drugs.  32 (2023)  5 - p. 417-427 , 2023
Link: https://doi.org/10.1080/..
 
?
4

Assessing the Interchangeability of AVT02 and Humira® in Pa..:

Feldman, Steven R. ; Kay, Richard ; Reznichenko, Nataliya...
BioDrugs.  37 (2023)  4 - p. 551-567 , 2023
Link: https://doi.org/10.1007/..
 
?
5

42913 Assessment of Therapeutic Equivalence Between Candida..:

Stroissnig, Heimo ; Feldman, Steven ; Berti, Fausto...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB124 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Joint analysis of PK and immunogenicity outcomes using fact..:

Haliduola, Halimu N. ; Berti, Fausto ; Stroissnig, Heimo...
BMC Medical Research Methodology.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
7

A multicenter, randomized, open-label, 2-arm parallel study..:

Wynne, Christopher ; Schwabe, Christian ; Stroissnig, Heimo...
Expert Opinion on Biological Therapy.  23 (2022)  8 - p. 773-780 , 2022
Link: https://doi.org/10.1080/..
 
?
8

A randomized, adaptive design, double-blind, 3-arm, paralle..:

Wynne, Christopher ; Schwabe, Christian ; Lemech, Charlotte...
Expert Opinion on Investigational Drugs.  31 (2022)  9 - p. 965-976 , 2022
Link: https://doi.org/10.1080/..
 
?
9

Assessment of real-life patient handling experience of AVT0..:

Damjanov, Nemanja ; Kirvalidze, Nana ; Kurashvili, Nana...
Expert Opinion on Biological Therapy.  23 (2022)  8 - p. 781-789 , 2022
Link: https://doi.org/10.1080/..
 
?
10

Efficacy, Safety and Immunogenicity of AVT02 Versus Origina..:

Feldman, Steven R. ; Reznichenko, Nataliya ; Pulka, Grazyna...
BioDrugs.  35 (2021)  6 - p. 735-748 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Thiophen als Strukturelement physiologisch aktiver Substanz..:

Binder, Dieter ; Koch, Andreas ; Rovenszky, Franz.
Archiv der Pharmazie.  325 (1992)  12 - p. 797-801 , 1992
Link: https://doi.org/10.1002/..
 
?
12

Thiophen als Strukturelement physiologisch aktiver Substanz..:

Binder, Dieter ; Schnait, Heinz ; Rovenszky, Franz..
Archiv der Pharmazie.  324 (1991)  4 - p. 219-221 , 1991
Link: https://doi.org/10.1002/..
 
?
13

Assessing the Interchangeability of AVT02 and Humira(®) in ..:

Feldman, Steven R ; Kay, Richard ; Reznichenko, Nataliya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197027/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Joint analysis of PK and immunogenicity outcomes using fact..:

Haliduola, Halimu N ; Berti, Fausto ; Stroissnig, Heimo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547438/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Efficacy, Safety and Immunogenicity of AVT02 Versus Origina..:

Feldman, Steven R ; Reznichenko, Nataliya ; Pulka, Grazyna...
Feldman , S R , Reznichenko , N , Pulka , G , Kingo , K , George Galdava , Berti , F , Sobierska , J , Dias , R , Guenzi , E , Hendrik Otto , Haliduola , H N , Kay , R & Stroissnig , H 2021 , ' Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis : A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study ' , BioDrugs , vol. 35 , no. 6 , pp. 735-748 . https://doi.org/10.1007/s40259-021-00502-w.  , 2021
Link: https://portal.findresea..
 
1-15